Filter
82
Filtered Results: 82
Text search:
Multisystemic
Inflammatory
Syndrome
Featured
Recommendations
20
New Publications
4
Language
Document type
Guidelines
46
Fact sheets
12
Manuals
8
Studies & Reports
6
No document type
5
Training Material
2
Strategic & Response Plan
2
Resource Platforms
1
Countries / Regions
Brazil
10
Germany
5
Russia
4
India
4
Rwanda
2
Syria
2
Nigeria
2
Mozambique
2
Latin America and the Carribbean
2
Middle East and North Africa
2
Western and Central Europe
2
Yemen
2
Colombia
1
Ukraine
1
Sierra Leone
1
Malawi
1
Africa
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
East and Southern Africa
1
Argentina
1
South Africa
1
Uganda
1
South Sudan
1
Liberia
1
Authors & Publishers
Publication Years
Category
COVID-19
30
Guidelines
18
Studies & Reports
3
Pediatrics
2
Policies
2
Women & Child Health
2
Paediatrics
1
Hepatitis
1
Palliative Care
1
NCD
1
Hemorrhagic Fever
1
Clinical Guidelines
1
Capacity Building
1
Palliative Care
1
Respiratory Infections
1
Communicable Diseases
1
HIV & STI
1
TB
1
Toolboxes
Country specific documents
21
Paediatrics
19
Clinical Guidelines
12
Long COVID/ Post-COVID Syndrome
10
Educational Settings
7
Inactivated COVID-19 Vaccines
5
Infection Control General
4
For Parents & Children
4
Immunization Guidelines
4
Biontech/Pfizer Comirnaty
3
Treatment Guidelines
2
Prevention & Preparedness
2
Surveillance & Contact tracing
2
COVID-19
2
Training, others
2
For Migrants & Refugees
2
Scientific & Research Studies
2
Gender Aspects
2
Access & Strategy
2
Moderna
2
Ebola
1
Livestock production
1
Context & Facts, Travel Advice
1
Clinical Aspects
1
For Pregnant Women
1
Prison & Detention
1
Child Protection
1
HIV and COVID-19
1
COVID-19
1
Oxygen Therapy
1
Hospital Readiness/Essential Health Services
1
Vaccine Candidates & Research
1
TB/COVID-19
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Covaxin
1
Research & Pipeline
1
Others
1
Palliative Care
1
Guidelines & Manuals
1
Prevention & Measures
1
Co-Morbidities (except TB)
1
Public Health Administration
1
23 Dec 2020. The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, based on the experience in the EU from August–December, 2020. This document also addresses transmissio...
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
16.7.2021
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
This guideline covers identifying, assessing and managing the long-term effects of COVID-19, often described as ‘long COVID’. It makes recommendations about care in all healthcare settings for adults, children and young people who have new or ongoing symptoms 4 weeks or more after the start of a...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Updated Treatment Guidelines
Critical preparedness, readiness and response actions for COVID-19
Interim Guidance - 27 May 2021
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
first issued 18 August 2022
Update, 23 de junio de 2022
